Nestle F O, Thompson C, Shimizu Y, Turka L A, Nickoloff B J
Department of Pathology, University of Michigan, Ann Arbor 48109-0602.
Cell Immunol. 1994 Jun;156(1):220-9. doi: 10.1006/cimm.1994.1166.
Highly purified populations of dendritic cells (DCs) can be isolated from various tissues such as skin and blood. These sites are likely to encounter secreted toxins of bacteria such as superantigens. In vivo, DCs express the cell surface molecule B7, a counterreceptor for CD28 which provides costimulation to resting T cells. Highly purified preparations of DCs obtained from the epidermis and dermis of normal skin as well as blood were used to study the role of B7 in superantigen presentation to autologous T cells, as well as in alloantigen responses. We compared these results to those obtained with nondendritic antigen presenting cells (APCs) such as mononuclear cells derived from the Ficoll-Hypaque interface (PBMCs). All DC populations strongly express B7, and in a purely autologous system staphylococcal enterotoxin B (SEB)-mediated T cell proliferation was inhibited by 55-85% using a soluble chimeric fusion protein (i.e., CTLA4Ig), a potent inhibitor of CD28:B7 interaction. In contrast, while T cells also proliferated vigorously when stimulated by SEB in the presence of autologous PBMC (which only weakly express B7), costimulation was not inhibited by CTLA4Ig. In allogeneic responses, DCs were also more potent stimulators compared to PBMC, but both types of APC:T cell reactions were almost completely inhibited by CTLA4Ig (> 90%). For both SEB-mediated reactions and alloantigen reactions, the relative importance of LFA-1 and HLA-DR was similar between DCs and PBMCs. The data indicate that these DCs express B7, which can function in the SEB-driven response of autologous T cells, as well as in allogeneic T cell reactions. Overall, when comparing the relative costimulatory capabilities of different types of APCs, it appears the relatively low level of B7 expressed by PBMC functioned effectively in allogeneic reactions, whereas only the higher levels of B7 expressed by these DC populations functioned in SEB-mediated T cell responses.
高纯度的树突状细胞(DCs)群体可从各种组织如皮肤和血液中分离出来。这些部位可能会接触到细菌分泌的毒素,如超抗原。在体内,DCs表达细胞表面分子B7,它是CD28的反受体,能为静止的T细胞提供共刺激信号。从正常皮肤的表皮和真皮以及血液中获得的高纯度DCs制剂被用于研究B7在向自体T细胞呈递超抗原以及在同种异体抗原反应中的作用。我们将这些结果与用非树突状抗原呈递细胞(APC)如从Ficoll-Hypaque界面获得的单核细胞(PBMCs)所得到的结果进行比较。所有DC群体都强烈表达B7,并且在一个纯自体系统中,使用可溶性嵌合融合蛋白(即CTLA4Ig,一种CD28:B7相互作用的有效抑制剂),葡萄球菌肠毒素B(SEB)介导的T细胞增殖被抑制了55 - 85%。相比之下,虽然当在自体PBMC(其仅微弱表达B7)存在的情况下用SEB刺激时T细胞也能强烈增殖,但共刺激并未被CTLA4Ig抑制。在同种异体反应中,与PBMC相比,DCs也是更强有力的刺激物,但两种类型的APC:T细胞反应几乎都被CTLA4Ig完全抑制(> 90%)。对于SEB介导的反应和同种异体抗原反应,DCs和PBMCs之间LFA-1和HLA-DR的相对重要性相似。数据表明这些DCs表达B7,其能在自体T细胞的SEB驱动反应以及同种异体T细胞反应中发挥作用。总体而言,当比较不同类型APC的相对共刺激能力时,似乎PBMC表达的相对低水平的B7在同种异体反应中有效发挥作用,而只有这些DC群体表达的较高水平的B7在SEB介导的T细胞反应中发挥作用。